Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The overall objective of the study is to evaluate the safety and efficacy of rabbit
antithymocyte globulin in the treatment of Graves orbitopathy (GO) after ineffective
treatment with moderate-to-high doses of glucocorticoids.